共 87 条
[2]
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
[J].
DIABETES OBESITY & METABOLISM,
2015, 17 (03)
:268-275
[4]
[Anonymous], MICR 20 INTR RED BOO
[5]
[Anonymous], AM DIABETES ASS JDRF
[6]
[Anonymous], NADAC NAT AV DRUG AC
[7]
[Anonymous], 2015, FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
[8]
[Anonymous], 2018, DIABETES CARE, DOI DOI 10.1007/S11548-018-1807-61